Canopy Growth Corp operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Canopy Growth Corp with three other pharmaceutical manufacturers in North America: C21 Investments Inc (2020 sales of 49.93 million Canadian Dollars [US$37.21 million] ), Ventura Cannabis and Wellness Corp (14.27 million Canadian Dollars [US$10.63 million] ), and Cyanotech Corporation which is based in UNITED STATES ($31.90 million of which 81% was Packaged sales).

Sales Analysis. During the year ended March of 2020, sales at Canopy Growth Corp were C$398.77 million (US$297.15 million). This is an increase of 76.2% versus 2019, when the company's sales were C$226.34 million. This was the fifth consecutive year of sales increases at Canopy Growth Corp (and since 2015, sales have increased a total of 20,920%).